Inhaled nitric oxide prevents experimental platelet activating factor- induced shock

Archives of Surgery

Volumn 131, Issue 8, 1996, Pages 855-860

  Emil, Sherif ^a   Berkeland, Joel ^a   Kosi, Mahmoud ^a   Atkinson, James ^a,b  

^a CHILDREN S HOSPITAL LOS ANGELES   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; DOSE RESPONSE; HEART INDEX; HEMODYNAMIC MONITORING; INHALATIONAL DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SHOCK; THROMBOCYTE ACTIVATION; VASCULAR RESISTANCE;

EID: 0029780659     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.1996.01430200065012     Document Type: Conference Paper

References (32)

1. Andersen BO, Bensard DD, Harken AH. The role of platelet activating factor and its antagonists in shock, sepsis, and multiple organ failure. Surg Gynecol Obstet. 1991;172:415-424.
2. Lefer AM. Induction of tissue injury and altered cardiovascular performance by platelet-activating factor: relevance to multiple system organ failure. Crit Care Clin. 1989;5:331-351.
3. Koltai M, Hosford D, Braquet PG. Platelet-activating factor in septic shock. New Horiz. 1993;1:87-95.
4. Goldstein RE, Ezra D, Laurindo FRM, Feuerstein GZ. Coronary and pulmonary vascular effects of leukotrienes and PAF-acether. Pharmacol Res Comm. 1986; 18(suppl):151-162.
5. Hoffman MJ, Greenfield LJ, Sugerman HJ, Tatum JL. Unsuspected right ventricular dysfunction in shock and sepsis. Ann Surg. 1983;198:307-319.
6. Sibbald WJ, Driedger AA. Right ventricular function in acute disease states: pathophysiologic considerations. Crit Care Med. 1983;11:339-345.
7. Reuse C, Frank N, Contempre B, Vincent JL. Right ventricular function in septic shock. Intensive Care Med. 1988;14:486-487.
8. Dhainaut JF, Lanore JJ, de Gournay JM, et al. Right ventricular dysfunction in patients with septic shock. Intensive Care Med. 1988;14:488-491.
9. Parker MM, McCarthy KE, Ognibene FP, Parrillo JE. Right ventricular dysfunction and dilatation, similar to left ventricular changes, characterize the cardiac depression of septic shock in humans. Chest. 1990;97:126-131.
10. Redl G, Germann P, Plattner H, Hammerle A. Right ventricular function in early septic shock slates. Intensive Care Med. 1993;19:3-7.
11. Szabo C. Alterations in nitric oxide production in various forms of circulatory shock. New Horiz. 1995;3:2-32.
12. Bessin P, Bonnet J, Apffel D, et al. Acute circulatory collapse caused by platelet-activating factor (PAF-acether) in dogs. Eur J Pharmacol. 1983;86:403-413.
13. Yamanaka S, Miura K, Yukimura T, Okumura M, Yamamoto K. Putative mechanism of hypotensive action of platelet-activating factor in dogs. Circ Res. 1992; 70:893-901.
14. Camussi G, Bussolino F, Salvidio G, Baglioni C. Tumor necrosis factor/ cachectin stimulates peritoneal macrophages, polymorphonuclear neutrophils, and vascular endothelial cells to synthesized and release platelet-activating factor. J Exp Med. 1987;166:1390-1404.
15. Handley DA, Tomesch JC, Saunders RN. Inhibition of PAF-induced systemic responses in the rat, guinea pig, dog, and primate by the receptor antagonist SRI 63-441. Thromb Haemost. 1986;56:40-44.
16. Stanton AWB, Izumi T, Antoniw JW, Piper PJ. Platelet-activating factor (Paf) antagonist, WEB 2086, protects against Paf-induced hypotension in Macaca fascicularis. Br J Pharmacol. 1989;97:643-646.
17. Kuipers B, van der Poll T, Levi M, et al. Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzees. J Immunol. 1994;152:2438-2446.
18. Booke M, Meyer J, Lingnau W, Hinder F, Traber LD, Traber DL. Use of nitric oxide synthase inhibitors in animal models of sepsis. New Horiz. 1995;3:123-138.
19. Nava E, Palmer RMJ, Moncada S. Inhibition of nitric oxide synthesis in septic shock: how much is beneficial? Lancet. 1991;338:1555-1557.
20. Petros A, Bennett D, Vallance P. Effects of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet. 1991;338:1557-1558.
21. Gomez-Jimenez J, Salgado A, Mourelle M, et al. L-Arginine: nitric oxide pathway in endotoxemia and human septic shock. Crit Care Med. 1995;23:253-258
22. G-nitro-L-arginine on shock induced by endotoxin and by platelet activating factor in dogs. Eur J Pharmacol. 1993;250:465-467.
23. Szabo C, Wu CC, Mitchell JA, et al. Platelet-activating factor contributes to the induction of nitric oxide synthase by bacterial lipopolysaccharide. Circ Res. 1993;73:991-999.
24. Moritoki H, Hisayama T, Takeuchi S, Miyano H, Kondoh W. Involvement of nitric oxide pathway in the PAF-induced relaxation of rat thoracic aorta. Br J Pharmacol. 1992;107:196-201.
25. Minnard EA, Shou J, Naama H, Cech A, Gallagher H, Daly JM. Inhibition of nitric oxide synthesis is detrimental during endotoxemia. Arch Surg. 1994; 129:142-148.
26. Robertson FM, Offner PJ, Ciceri DP, Becker WK, Pruitt BA. Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock. Arch Surg. 1994;129:149-156.
27. Ogura H, Offner PJ, Saitoh D, et al. The pulmonary effect of nitric oxide synthase inhibition following endotoxemia in a swine model. Arch Surg. 1994; 129:1233-1239.
28. G-methyl-L-arginine, an inhibitor of nitric oxide formation, acts synergistically with dobutamine to improve cardiovascular performance in endotoxemic dogs. Crit Care Med. 1994; 22:1835-1840.
29. Wang P, Ba ZF, Chaudry IH. Nitric oxide: to block or enhance its production during sepsis? Arch Surg. 1994;129:1137-1143.
30. Emil S, Kosi M, Berkeland J, Kanno S, Newth C, Atkinson J. Severity of hypoxia predicts response to nitric oxide in a porcine pulmonary hypertension model. J Pediatr Surg. 1995;30:930-936.
31. Berger JI, Gibson RL, Redding GJ, Standaert TA, Clarke WR, Truog WE. Effect of inhaled nitric oxide during group B streptococcal sepsis in piglets. Am Rev Respir Dis. 1993;147:1080-1086.
32. Offner PJ, Ogura H, Jordan BS, Pruitt BA, Cioffi WG. Effects of inhaled nitric oxide on right ventricular function in endotoxin shock. J Trauma. 1995;39: 179-186.